Dow Up0.18% Nasdaq Up0.01%

Anacor Pharmaceuticals, Inc. (ANAC)

-NasdaqGM
21.11 0.00(0.00%) 12:56PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 2,931   4,158   8,485   3,611  
Cost of Revenue -   -   -   -  
Gross Profit 2,931   4,158   8,485   3,611  
Operating Expenses
Research Development19,261  15,935  12,796  12,460  
Selling General and Administrative7,095  8,328  4,039  6,809  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (23,425) (20,105) 134,150   (15,658)
Income from Continuing Operations
Total Other Income/Expenses Net17  22  141,906  (16)
Earnings Before Interest And Taxes(23,408)(20,083)132,175  (15,674)
Interest Expense1,100  1,089  1,102  1,135  
Income Before Tax(24,508)(21,172)131,073  (16,809)
Income Tax Expense -   -  1,706   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(24,508)(21,172)129,367  (16,809)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (24,508) (21,172) 130,748   (16,809)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (24,508) (21,172) 130,748   (16,809)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.